Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
- Author:
Ji-Jun WANG
1
;
Hong-Mei JING
;
Hong-Wei SHEN
;
Jiao-Sheng XU
;
Min LI
;
Zi-Feng GAO
;
Xiao-Yan KE
Author Information
1. Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Bone Marrow;
pathology;
Female;
Humans;
Male;
Middle Aged;
Retrospective Studies;
Waldenstrom Macroglobulinemia;
diagnosis;
pathology;
therapy
- From:
Journal of Experimental Hematology
2010;18(6):1494-1498
- CountryChina
- Language:Chinese
-
Abstract:
In order to investigate the clinical manifestations, diagnosis, therapy and prognosis of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM), 16 patients with LPL/WM were analyzed retrospectively. The results showed that the average age of 16 patients with LPL/WM was 65.1 years old, the most common syndromes were anemia and hyperviscosity syndrome, bone marrows were composed of small lymphocyte, admixed with variable numbers of plasma cells and plasmacytoid lymphocytes. And lymph node biopsy revealed that most cells expressed B-cell-associated antigen. Among the 16 cases, complete remission was 25%, overall response rate (ORR) was 81.3%, overall survival time was 6 to 108 months. 3 patients died and survival rate was 81.3 %. It is concluded that the clinical course of LPL/WM is typically indolent. These patients can acquire remission in clinic, but can not be cured, some of them can transform into patients with more malignant lymphoma.
